BMG Pharma S.r.l (“BMG”) announces the launch of its proprietary product Ialuxid® Gel under the new trademark HPO Skin Protect owned by Centro Internacional de Cosmiatria, S.A.P.I. de C.V. (“FARMAPIEL”) in Mexico.

Milan, Italy: BMG Pharma S.r.l (“BMG”) announces the launch of its proprietary product Ialuxid® Gel under the new trademark HPO Skin Protect owned by Centro Internacional de Cosmiatria, S.A.P.I. de C.V. (“FARMAPIEL”) in Mexico

Milan, 18th May, 2015

BMG Pharma S.r.l. (“BMG”) is pleased to announce that, after the signature of a Supply and Distribution Agreement with Centro Internacional de Cosmiatria, S.A.P.I. de C.V., Mexico (“FARMAPIEL”) on July 28, 2014, FARMAPIEL achieved in few months the registration of the trademark HPO Skin Protect under its ownership in Mexico (the Product) and launched the Product in its territory with very good success.

Thanks to its innovative formula, HPO Skin Protect, helps to reduce the growth and reproduction of acne bacteria, reducing the bacterial enzymes responsible for the production of irritant fatty acid.
HPO Skin Protect also helps the reduction of other infections such as the ones in the inguinal area, folliculitis etc…
HPO Skin Protect reduces as well the irritation on the skin thanks to its soothing agents and along with its regenerative components, encourages the repair process of the skin.

”We are proud to cooperate with FARMAPIEL which achieved the registration of HPO Skin Protect in a very short time” – said Marco Mastrodonato, CEO of BMG – “We are pleased to offer our product HPO Skin Protect to allow patients to receive the best care possible by using an innovative delivery technology to provide fast pain relief to skin infections. This partnership is a major milestone for BMG as it allows our company to enter the Mexican market”.

“FARMAPIEL is convinced that HPO Skin Protect will bring clear benefits to Mexican patients and is pleased to work with BMG to continue exploring new therapies in dermatology for the future” – said Ricardo Spínola, CEO of FARMAPIEL-.

About HPO Skin Protect
HPO Skin Protect is offered in 30 ml tube and is a unique combination gel formulation which can be used to treat acne lesions and to reduce the growth of acne bacteria.
The key ingredients in this novel formulation – hyaluronic acid, glycine and hydrogen peroxide – allow the gel to form a protective film against external agents and prevents the bacterial infections.

About FARMAPIEL:
FARMAPIEL is a Mexican company founded in 1991 aiming to take a leadership position in the dermatology market in Mexico. Currently, FARMAPIEL has a solid line of dermatology products across five categories including, wound/scar treatment, clarifying agents, anti-ageing products, anti-acne treatment and feminine health.

FARMAPIEL holds a solid position to serve dermatologists, plastic surgeons, healthcare professionals and their patients with dermatological products of the highest quality and with the best professional standards in the industry.

For press releases and other company information, visit:

www.farmapiel.com
and contact: Mrs. Mónica Zárate
mzarate@farmapiel.com

About BMG
BMG is a specialty pharmaceutical company with head office in Milan, Italy, leveraging its proprietary technology to develop products that address unmet needs of patients. The company is currently focused on cancer supportive care, dermatology gynecology, ENT and oral health. BMG Pharma. is dedicated to helping patients, pharmacists and physicians by providing valuable and innovative products to the market.

The Company’s key features are:

  • Full involvement in business and partnering
  • Presence in different therapeutic areas
  • Specific regulatory strategies for each product as Prescription and OTC Medical Devices in EC and US to allow rapid market introduction. BMG focuses on bringing products to market quickly with supportive clinical data.
  • IP protection for most of the products and technologies

For press releases and other company information, visit:
www.bmgpharma.com
and contact : Mrs. Loredana Galli
loredana.galli@bmgpharma.com

BMG Pharma S.r.l.